Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Shares Issued (2018 - 2024)

Historic Shares Issued for Autolus Therapeutics (AUTL) over the last 7 years, with Q1 2024 value amounting to $550.0 million.

  • Autolus Therapeutics' Shares Issued changed N/A to $550.0 million in Q1 2024 from the same period last year, while for Dec 2024 it was $550.0 million, marking a year-over-year increase of 203685185.19%. This contributed to the annual value of $550.0 million for FY2024, which is 203685185.19% up from last year.
  • Per Autolus Therapeutics' latest filing, its Shares Issued stood at $550.0 million for Q1 2024.
  • Autolus Therapeutics' 5-year Shares Issued high stood at $550.0 million for Q1 2024, and its period low was -$356000.0 during Q3 2021.
  • For the 5-year period, Autolus Therapeutics' Shares Issued averaged around $80.0 million, with its median value being $5.8 million (2020).
  • Its Shares Issued has fluctuated over the past 5 years, first surged by 185765000.0% in 2020, then crashed by 48360.66% in 2021.
  • Over the past 5 years, Autolus Therapeutics' Shares Issued (Quarter) stood at $5.8 million in 2020, then skyrocketed by 1786.48% to $109.4 million in 2021, then surged by 49.7% to $163.7 million in 2022, then crashed by 99.99% to $23000.0 in 2023, then skyrocketed by 2391104.35% to $550.0 million in 2024.
  • Its Shares Issued was $550.0 million in Q1 2024, compared to $23000.0 in Q4 2023 and $4000.0 in Q3 2023.